The Klein Law Firm
NEW YORK, NY / ACCESSWIRE / July 15, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Frequency Therapeutics, Inc. (NASDAQ:FREQ)
Class Period: November 16, 2020 - March 22, 2021
Lead Plaintiff Deadline: August 2, 2021
The complaint alleges that throughout the class period Frequency Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.
Learn about your recoverable losses in FREQ: https://www.kleinstocklaw.com/pslra-1/frequency-therapeutics-inc-loss-submission-form?id=17674&from=1
Athira Pharma, Inc. (NASDAQ:ATHA)
This lawsuit is on behalf of investors who purchased Athira Pharma, Inc. (NASDAQ: ATHA) between September 18, 2020 and June 17, 2021 and/or purchased common stock in or traceable to the Company's registration statement issued in connection with the Company's September 2020 initial public offering priced at $17.00 per share.
Lead Plaintiff Deadline: August 24, 2021
The ATHA lawsuit alleges that throughout the class period, Athira Pharma, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the research conducted by Defendant Kawas, which formed the foundation for Athira's product candidates and intellectual property, was tainted by Kawas' scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.
Learn about your recoverable losses in ATHA: https://www.kleinstocklaw.com/pslra-1/athira-pharma-inc-loss-submission-form?id=17674&from=1
Full Truck Alliance Co. Ltd. (NYSE:YMM)
This lawsuit is on behalf of persons who purchased or otherwise acquired Full Truck's securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Full Truck's June 2021 initial public offering.
Lead Plaintiff Deadline: September 10, 2021
The complaint alleges that throughout the class period Full Truck Alliance Co. Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) Full Truck's apps Yunmanman and Huochebang would face an imminent cybersecurity review by the Chinese government; (2) the Chinese government would require Full Truck to suspend new user registration; (3) FTA needed to conduct a "comprehensive self-examination of any cybersecurity risks"; (4) Full Truck needed to "continue to improve its cybersecurity systems and technology capabilities"; and (5) as a result, Defendants' public statements were materially false and misleading at all relevant times and negligently prepared.
Learn about your recoverable losses in YMM: https://www.kleinstocklaw.com/pslra-1/full-truck-alliance-co-ltd-loss-submission-form?id=17674&from=1
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm
View source version on accesswire.com:
https://www.accesswire.com/655685/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-FREQ-ATHA-and-YMM
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Karbon-X Project Inc.28.3.2024 20:02:55 CET | Press release
Karbon-X and Drax Group Partner in Major Step for Carbon Removal Market
Naomi Sarna Designs28.3.2024 17:03:43 CET | Press release
703-Carat L'Heure Bleu Tanzanite Carving Sets New GUINNESS WORLD RECORDS(TM) Title as World's Largest Cut Tanzanite
INFORMA MARKETS - INFRASTRUCTURE AND CONSTRUCTION28.3.2024 16:43:42 CET | Press release
JLC LIVE New England Draws Nearly 9,000 Industry Professionals to Learn from Expert Builders and Discover Products Shaping the Dynamic Residential Construction Sector
mymediset28.3.2024 12:12:56 CET | Press release
mymediset LiveSync: mymediset and Terso Solutions Announce a New Partnership to Deliver a Revolutionary Supply Chain Platform for Live Consignment Tracking and Automation
Innodata Inc.27.3.2024 14:03:46 CET | Press release
Innodata to Host Webinar on Safeguarding LLM Deployment: Model Evaluation and Red Teaming
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom